Epidemic response to COVID-19 in pharmaceutical and healthcare industries series - Issue 1

Pharmaceutical and medical device companies are taking a variety of proactive measures to deal with this outbreak in the areas of R&D registration, production and supply chain and marketing. And a number of patient centric digital innovations have emerged from disease diagnosis and consultation, drug discovery and delivery, patient and public education and patient information management.